Fig. 3From: Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?Follow-up contrast-enhanced T1-weighted and fat-saturated MRI scan of the patient with mucoepidermoid carcinoma of the paranasal sinus 6 weeks post completion of radiotherapy (a: axial; b: coronal)Back to article page